Ads
related to: current research on multiple sclerosis- Living Beyond MS
Learn More About MS Treatment.
Download a Free MS Treatment Guide.
- MS Early Signs & Symptoms
Get a Free Multiple Sclerosis Guide
Learn About MS Signs & Symptoms
- Progressive MS
Download Our Free Information Guide
Discover MS Symptoms & Treatment
- Relapsing MS
Learn About Relapsing MS.
Download a Free Treatment Guide.
- Living Beyond MS
benchmarkguide.com has been visited by 10K+ users in the past month
doconsumer.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Research in multiple sclerosis may find new pathways to interact with the disease, improve function, curtail attacks, or limit the progression of the underlying disease. Many treatments already in clinical trials involve drugs that are used in other diseases or medications that have not been designed specifically for multiple sclerosis .
The Corinne Goldsmith Dickinson Center for Multiple Sclerosis is a multiple sclerosis research and treatment center in New York City.. In 2005, it received one of the largest grants ever given for MS research in the United States, a $25 million grant from the National Institutes of Health to study the effectiveness of combining two disease-modifying drugs, and the individual factors that ...
Comparative Effectiveness Research (CER) is an emerging field in Multiple Sclerosis treatment. The response of the disease to the different available medications at this moment cannot be predicted, and would be desirable. [17] But the ideal target is to find subtypes of the disease that respond better to a specific treatment.
Multiple sclerosis (MS) is an autoimmune disease resulting in damage to the insulating covers of nerve cells in the brain and spinal cord. [3] As a demyelinating disease , MS disrupts the nervous system's ability to transmit signals , resulting in a range of signs and symptoms , including physical, mental , and sometimes psychiatric problems.
[46] [47] Research in this area has focused on the efficacy of estriol as a treatment to reduce symptoms of relapse-remitting multiple sclerosis in non-pregnant women. [48] [49] [50] ibudilast: A phase II trial shows that Ibudilast does not reduce lesion rate, but prevents them to turn into black holes.
Nearly 2.3 million people are estimated to be living with multiple sclerosis around the world, but when Montel Williams received his official diagnosis back in 1999, not much was known about the ...
Ads
related to: current research on multiple sclerosisbenchmarkguide.com has been visited by 10K+ users in the past month
doconsumer.com has been visited by 10K+ users in the past month